Are You Ready to Elevate Your Knowledge? Integrating AAD Guideline Updates to Optimize Patient Care in Atopic Dermatitis

Deepen your understanding of the American Academy of Dermatology guidelines update for atopic dermatitis, including expert-informed strategies regarding systemic therapy to treat moderate to severe disease, through an on-demand webcast with accompanying slides and expert-written ClinicalThought commentaries. 

Share

Program Content

Activities

Systemic Treatment for Atopic Dermatitis
Updated AAD Guidance on Systemic Treatment for Atopic Dermatitis
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 18, 2024

Expires: July 17, 2025

Q&A on Atopic Dermatitis
Expert Answers to Compelling Questions About Managing Moderate to Severe Atopic Dermatitis
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 16, 2024

Expires: August 15, 2025

Activities

AAD Guidelines in Atopic Dermatitis
Are You Ready to Elevate Your Knowledge? Integrating AAD Guideline Updates to Optimize Patient Care in Atopic Dermatitis
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 19, 2024

Expires: July 18, 2025

Activities

Elevate Atopic Dermatitis Care
Are You Ready to Elevate Your Knowledge? Integrating AAD Guideline Updates to Optimize Patient Care in Atopic Dermatitis
Video
Congratulations: You achieved a completion on 04/09/2022

Released: August 13, 2024

Expires: August 12, 2025

Faculty

cover img faculity

Victoria Garcia-Albea, PNP, DCNP

Director, Lahey Dermatology Nurse Practitioner Training Program
Lahey Dermatology
Burlington, Massachusetts

cover img faculity

Benjamin Ungar, MD

Director, Alopecia Center of Excellence
Director, Rosacea & Seborrheic Dermatitis Clinic
Assistant Professor, Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, New York

Provided by

ProCE Banner

Provided by Partners for Advancing Clinical Education (PACE)

Supporters

Supported by an educational grant from Sanofi and Regeneron Pharmaceuticals.

Regeneron Pharmaceuticals

Sanofi